A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
Ningning Liu(State Key Laboratory of Respiratory Disease), Jinbao Liu(State Key Laboratory of Respiratory Disease)
Cited by 76
Related Papers
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
|Oncotarget|2014|170
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
|Cell Death and Disease|2017|118
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
|Cell Death and Disease|2017|97
USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
|Cell Discovery|2019|97